A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAFV600E-MutantKRASWild-Type Metastatic Colorectal Cancer is a research paper published in The Oncologist (2023). On theSindex it has a DataRank of 1.2. It has been cited 53 times, with 52 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.598
From this paper's citation signal
Citation Network Contribution
0.578
From 39 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 52 citers.
NCI
Grant: K12 CA088084
CG Johnson Foundation
Khalifa Bin Zayed Al Nahyan Foundation
NIH
MeSH Terms
Keywords